GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (NAS:THTX) » Definitions » Buyback Yield %

Theratechnologies (Theratechnologies) Buyback Yield % : 0.00 (As of Jun. 10, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Theratechnologies Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Theratechnologies's current buyback yield was 0.00%.


Theratechnologies Buyback Yield % Historical Data

The historical data trend for Theratechnologies's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Buyback Yield % Chart

Theratechnologies Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -14.65 -1.44 -34.63

Theratechnologies Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Theratechnologies's Buyback Yield %

For the Biotechnology subindustry, Theratechnologies's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Theratechnologies's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Theratechnologies's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Theratechnologies's Buyback Yield % falls into.



Theratechnologies Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Theratechnologies's Buyback Yield for the fiscal year that ended in Nov. 2023 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 25.16) / 72.6484
=-34.63%

Theratechnologies's annualized Buyback Yield for the quarter that ended in Feb. 2024 is calculated as

Buyback Yield=Net Issuance of Stock(Annualized) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) * Annualized Factor / Market Cap
=- (0 + 0) * 4 / 66.671
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the annualized quarterly data, the Repurchase of Stock and Issuance of Stock data used here is four times the quarterly (Feb. 2024) data.


Theratechnologies Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Theratechnologies's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Theratechnologies (Theratechnologies) Business Description

Traded in Other Exchanges
Address
2015, rue Peel, 11e etage, Montreal, QC, CAN, H3A 1T8
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.

Theratechnologies (Theratechnologies) Headlines

From GuruFocus

Theratechnologies Reports on its Annual Meeting of Shareholders

By sperokesalga sperokesalga 05-09-2023